tyrosine kinase inhibitor discontinuation Recently Published Documents

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Nk Cell ◽

Interferon Treatment ◽

Subsequent attempt tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia; a single institute experience

Hematological Oncology ◽

10.1002/hon.2896 ◽

2021 ◽

Author(s):

Hiroshi Ureshino ◽

Kazuharu Kamachi ◽

Atsujiro Nishioka ◽

Sho Okamoto ◽

Hiroo Katsuya ◽

...

Keyword(s):

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Optimal duration of imatinib treatment/deep molecular response for treatment‐free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial

British Journal of Haematology ◽

10.1111/bjh.17447 ◽

2021 ◽

Author(s):

Dennis D. H. Kim ◽

Igor Novitzky‐Basso ◽

Taehyung S. Kim ◽

Eshetu G. Atenafu ◽

Donna Forrest ◽

...

Keyword(s):

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Molecular Response ◽

Imatinib Treatment ◽

Optimal Duration ◽

Deep Molecular Response ◽

Treatment Free Remission ◽

Leukemic stem cells shall be searched in the bone marrow before “tyrosine kinase inhibitor‐discontinuation” in chronic myeloid leukemia

International Journal of Laboratory Hematology ◽

10.1111/ijlh.13528 ◽

2021 ◽

Author(s):

Osman Ilhan ◽

Zehra Narli Ozdemir ◽

Klara Dalva ◽

Aysenur Arslan ◽

Mufide Okay Ozgeyik ◽

...

Keyword(s):

Stem Cells ◽

Bone Marrow ◽

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Leukemic Stem Cells ◽

Successful tyrosine kinase inhibitor discontinuation outside clinical trials — data from the population‐based Swedish chronic myeloid leukaemia registry

British Journal of Haematology ◽

10.1111/bjh.17392 ◽

2021 ◽

Author(s):

Hjalmar Flygt ◽

Fredrik Sandin ◽

Torsten Dahlén ◽

Arta Dremaine ◽

Anna Lübking ◽

...

Keyword(s):

Clinical Trials ◽

Chronic Myeloid Leukaemia ◽

Tyrosine Kinase ◽

Myeloid Leukaemia ◽

Kinase Inhibitor ◽

Population Based ◽

Budget Impact of Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia With Sustained Deep Molecular Response

Value in Health ◽

10.1016/j.jval.2020.11.010 ◽

2021 ◽

Author(s):

Cyril Astrugue ◽

Antoine Bénard ◽

Pauline Bosco-Levy ◽

Stéphanie Dulucq ◽

Magali Rouyer ◽

...

Keyword(s):

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Budget Impact ◽

Kinase Inhibitor ◽

Molecular Response ◽

Deep Molecular Response ◽

Predictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia

World Journal of Clinical Oncology ◽

10.5306/wjco.v11.i12.996 ◽

2020 ◽

Vol 11 (12) ◽

pp. 996-1007

Author(s):

Ruth Stuckey ◽

Juan Francisco López-Rodríguez ◽

Santiago Sánchez-Sosa ◽

Adrián Segura-Díaz ◽

Nuria Sánchez-Farías ◽

...

Keyword(s):

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Tyrosine Kinase Inhibitor Discontinuation ◽

Predictive Indicators

Tyrosine kinase inhibitor discontinuation in the management of chronic myeloid leukemia: a critical review of the current practice

Expert Review of Hematology ◽

10.1080/17474086.2021.1852924 ◽

2020 ◽

Vol 13 (12) ◽

pp. 1311-1318

Author(s):

Massimo Breccia ◽

Fabio Efficace ◽

Gioia Colafigli ◽

Emilia Scalzulli ◽

Alessio Di Prima ◽

...

Keyword(s):

Tyrosine Kinase ◽

Critical Review ◽

Myeloid Leukemia ◽

Current Practice ◽

Kinase Inhibitor ◽

Tyrosine Kinase Inhibitor Discontinuation in Patients With Chronic Myeloid Leukemia

JAMA Oncology ◽

10.1001/jamaoncol.2020.5772 ◽

2020 ◽

Author(s):

Theodore P. Braun ◽

Brian J. Druker

Keyword(s):

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Withdrawal Syndrome After Tyrosine Kinase Inhibitor Discontinuation in Patients With Chronic Myeloid Leukemia in the Russian Prospective Study RU-SKI

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2019.12.019 ◽

2020 ◽

Vol 20 (5) ◽

pp. 267-271 ◽

Cited By ~ 2

Author(s):

Anna Petrova ◽

Ekaterina Chelysheva ◽

Oleg Shukhov ◽

Anastasiya Bykova ◽

Irina Nemchenko ◽

...

Keyword(s):

Tyrosine Kinase ◽

Prospective Study ◽

Withdrawal Syndrome ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽